Diana W. Shineman

Role for Akt3/Protein Kinase Bγ in Attainment of Normal Brain Size

Rachael Easton, Han Cho, Kristin Roovers et al. · Molecular and Cellular Biology · 2005 · 547 citations · Full text

Brain Development, Brain Science, Metabolic Remodeling +25

Mechanism of Ca2+ Disruption in Alzheimer's Disease by Presenilin Regulation of InsP3 Receptor Channel Gating

King‐Ho Cheung, Diana W. Shineman, Marioly Müller et al. · Neuron · 2008 · 448 citations · Full text

Signal Transduction, Alzheimer's Disease, Insp3 Receptor Channel +12

Modulation of Nuclear Factor-κB Activity by Indomethacin Influences Aβ Levels but Not Aβ Precursor Protein Metabolism in a Model of Alzheimer's Disease

Syaun Sung, Hengxuan Yang, Kunihiro Uryu et al. · American Journal Of Pathology · 2004 · 153 citations · Full text

Neurodegenerative Diseases, Alzheimer's Disease, Biochemistry +9

Accelerating drug discovery for Alzheimer's disease: best practices for preclinical animal studies

Diana W. Shineman, Guriqbal S. Basi, Jennifer L. Bizon et al. · Alzheimer s Research & Therapy · 2011 · 130 citations · Full text

Preclinical Therapeutics, Drug Target, Neurochemical Biomarkers +22

Current evidence for the clinical use of long-chain polyunsaturated N-3 fatty acids to prevent age-related cognitive decline and Alzheimer's disease

Penny A. Dacks, Diana W. Shineman, Howard Fillit · The journal of nutrition health & aging · 2013 · 67 citations · Full text

Neurodegenerative Diseases, Alzheimer's Disease, Aging +8